In Vitro-Selected Linezolid-Resistant Mycobacterium tuberculosis Mutants

Antimicrobial Agents and Chemotherapy
2008.0

Abstract

We aimed to generate linezolid-resistant Mycobacterium tuberculosis strains from 10 different, fully susceptible M. tuberculosis parental strains. Ten linezolid-resistant colonies could be isolated from six different parental strains, with the frequency of in vitro appearance ranging from 2×10⁻⁸ to 5×10⁻⁹. MIC values of resistant strains varied from 4 to 32 g/ml (parent strains had 1 g/ml). Genotypic characterization showed mutations in the 23S rRNA gene in five strains: four with G-to-T at position 2061 (MIC 32 g/ml) and one with G-to-T at 2576 (MIC 16 g/ml); five strains with MIC 4-8 g/ml had no mutations. Growth rate investigation revealed that resistant strains with 23S rRNA mutations had elevated time to detection (TTD, 10.10±3.49 days) compared to parental strains (5.93±1.84 days) and resistant strains without mutations (5.81±1.81 days). Isolated mutants can be divided into two classes corresponding to M. smegmatis clones: one with wild-type growth, lower MIC, no 23S rRNA mutation (non-ribosomal mechanism); the other with 23S rRNA alterations, high MIC, decreased growth. The G2061T mutation in M. tuberculosis is reported here for the first time.

Knowledge Graph

Similar Paper

In Vitro-Selected Linezolid-Resistant Mycobacterium tuberculosis Mutants
Antimicrobial Agents and Chemotherapy 2008.0
Mutations in 23S rRNA at the Peptidyl Transferase Center and Their Relationship to Linezolid Binding and Cross-Resistance
Antimicrobial Agents and Chemotherapy 2010.0
Emergence and Molecular Characterization of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates from the Delhi Region in India
Antimicrobial Agents and Chemotherapy 2010.0
Allelic Exchange and Mutant Selection Demonstrate that Common Clinical embCAB Gene Mutations Only Modestly Increase Resistance to Ethambutol in Mycobacterium tuberculosis
Antimicrobial Agents and Chemotherapy 2010.0
Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrB
Antimicrobial Agents and Chemotherapy 2009.0
In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis Complex Isolated in Taiwan over 10 Years
Antimicrobial Agents and Chemotherapy 2008.0
Mutations at embB Codon 306 Are an Important Molecular Indicator of Ethambutol Resistance in Mycobacterium tuberculosis
Antimicrobial Agents and Chemotherapy 2009.0
Transfer of embB Codon 306 Mutations into Clinical Mycobacterium tuberculosis Strains Alters Susceptibility to Ethambutol, Isoniazid, and Rifampin
Antimicrobial Agents and Chemotherapy 2008.0
Selection of Mutations To Detect Multidrug-Resistant Mycobacterium tuberculosis Strains in Shanghai, China
Antimicrobial Agents and Chemotherapy 2010.0
Linezolid Resistance in Staphylococcus aureus : Gene Dosage Effect, Stability, Fitness Costs, and Cross-Resistances
Antimicrobial Agents and Chemotherapy 2008.0